CapsoVision CV
NASDAQ CV
$6.00 -0.12 (-1.96%)
At close: Aug 20, 2026 · 10:01 AM UTC

CapsoVision (CV) Revenue (2024 - 2026)

CapsoVision (CV) posted Revenue of $3.9 million for Q4 2025, up 10.74% sequentially from $3.5 million in Q3 2025, and up 13.5% YoY from $3.5 million in Q4 2024.

CapsoVision (CV) Revenue (2024 - 2026) Analysis & Trends

CapsoVision has reported Revenue for 2 years, with the latest figure at $3.9 million in Q4 2025.

  • Quarterly Revenue rose 13.5% year-over-year to $3.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.2 million (changed N/A YoY) and the FY2025 annual result came in at $13.6 million, up 15.29% from the prior year.
  • Revenue climbed to $3.9 million in Q4 2025 per CV's latest filing, from $3.5 million in the prior quarter.
  • Over five years, Revenue peaked at $3.9 million in Q4 2025 and troughed at $2.8 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn 12.59 Bn
2 Stryker 130.69 Bn 127.22 Bn 4.50 Bn 6.59 Bn
3 Medtronic 120.89 Bn 111.67 Bn 6.41 Bn 9.81 Bn
4 Boston Scientific 75.26 Bn 74.72 Bn 3.85 Bn 5.44 Bn
5 Edwards Lifesciences 52.88 Bn 48.63 Bn 1.35 Bn 1.74 Bn
6 Dexcom 34.76 Bn 32.81 Bn 830.00 Mn 1.31 Bn
7 GE HealthCare Technologies 33.84 Bn 31.74 Bn 2.18 Bn 5.30 Bn
8 Koninklijke Philips 26.47 Bn 23.15 Bn 4.55 Bn 9.61 Bn
9 Steris 23.26 Bn 22.78 Bn 684.20 Mn 1.49 Bn
10 CapsoVision 299.63 Mn 290.55 Mn 1.87 Mn 3.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.64 Mn
Dec 31, 2025 3.92 Mn
Sep 30, 2025 3.54 Mn
Jun 30, 2025 3.32 Mn
Dec 31, 2024 3.45 Mn
Sep 30, 2024 2.97 Mn
Jun 30, 2024 2.84 Mn